Skip to main content
Positive top-line phase 3 data for lecanemab in early Alzheimer’s
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Positive top-line phase 3 data for lecanemab in early Alzheimer’s
User login
Username
Password
Reset your password
Concept
Lead
score
Healthcare and Medical Technology
1
1
Alzheimer Disease
0
0.99
Mild Cognitive Impairment
0
0.82
Brain
0
0.64
Drug Development
0
0.64
Biologic Therapy
0
0.6
Cerebrovascular Accident
0
0.52
Traumatic Brain Injury
0
0.48
Cerebral Hemorrhage
0
0.3
Cognitive Impairment
0
0.3
Biomarker
0
0.21
Clinical Research
0
0.21
Dementia
0
0.21
Edema
0
0.21
Grant
0
0.21
Hemorrhage
0
0.21
Impairment
0
0.21
Monoclonal Antibody
0
0.21
Specialty
Lead
score
Neurology & Neurosurgery
1
1
Pharmacist
0
0.8
Psychiatry
0
0.9
Edit Tags